semaglutide magnesium semaglutide magnesium Increasing beyond HERS

Purpose-built for physicians Semaglutide, tirzepatide not deemed cost-effective obesity therapies despite benefits Key takeaways: Semaglutide and tirzepatide were the least cost-effective of four obesity drugs examined in a microsimulation model

A popular medicine worldwide and in Israel Ozempic works by mimicking a hormone called glucagon-like peptide-1 (GLP-1) which targets areas of the brain that regulate appetite and food intake

Real customers

Research from the SURMOUNT trials shows that most people on tirzepatide reach a plateau between weeks 24 and 36, depending on their starting BMI

A shelf-stable treatment may be a better fit for you

Eligibility will be determined at the end of the clinical judgment and regulatory requirements